Prevalence and outcome of silent hypoxemia in COVID-19.
Minerva Anestesiol
; 87(3): 325-333, 2021 03.
Article
in English
| MEDLINE | ID: covidwho-1128285
ABSTRACT
BACKGROUND:
In the early stages of COVID-19 pneumonia, hypoxemia has been described in absence of dyspnea ("silent" or "happy" hypoxemia). Our aim was to report its prevalence and outcome in a series of hypoxemic patients upon Emergency Department admission.METHODS:
In this retrospective observational cohort study we enrolled a study population consisting of 213 COVID-19 patients with PaORESULTS:
Silent hypoxemic patients (68-31.9%) compared to the dyspneic hypoxemic patients (145-68.1%) showed greater frequency of extra respiratory symptoms (myalgia, diarrhea and nausea) and lower plasmatic LDH. PaOCONCLUSIONS:
Silent hypoxemia is remarkably present in COVID-19. The presence of dyspnea is associated with a more severe clinical condition.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Hypoxia
Type of study:
Cohort study
/
Experimental Studies
/
Observational study
/
Prognostic study
/
Randomized controlled trials
Topics:
Long Covid
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Minerva Anestesiol
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS